PubMed ID:
24674942
Public Release Type:
Journal
Publication Year: 2014
Affiliation: Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: william.lee@utsouthwestern.edu.
DOI:
https://doi.org/10.1016/j.cgh.2014.03.011
Authors:
Chung RT,
Durkalski V,
Durkalski V,
Lee WM,
Lee WM,
Attar N,
Balko J,
Battenhouse H,
Battenhouse H,
Blei A,
Brown R,
Cavazos J,
Crippin J,
Davern T,
Dillon C,
Fix O,
Fontana R,
Ganger D,
Goddard T,
Han SH,
Harrison E,
Hassanein T,
Hay J,
Hynan LS,
Karvellas CJ,
Lalani E,
Larson AM,
Liou I,
McCashland T,
McGuire B,
Munoz S,
Murray N,
Obaid A,
Pezzia C,
Reddy R,
Reuben A,
Rossaro L,
Samuel G,
Sanders C,
Sanders C,
Satyanarayana R,
Schilsky M,
Shaikh S,
Smith A,
Stravitz R,
US Acute Liver Failure Study Group,
Zaman A,
Zhao W
Studies:
Acute Liver Failure Study Group: Adult Acute Liver Failure Study
We investigated whether antimicrobial prophylaxis alters the incidence of bloodstream infection in patients with acute liver failure (ALF), and whether bloodstream infections affect overall mortality within 21 days after development of ALF.